pyrroles has been researched along with perflutren in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atri, M; Bjarnason, GA; Burns, PN; Hudson, JM; Lloyd, BA; Lueck, G; Milot, L; Sureshkumar, AR; Williams, R | 1 |
| Atri, M; Bjarnason, GA; Burns, PN; Hudson, JM; Karshafian, R; Milot, L; Williams, R | 1 |
1 trial(s) available for pyrroles and perflutren
| Article | Year |
|---|---|
Quantifying vascular heterogeneity using microbubble disruption-replenishment kinetics in patients with renal cell cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Contrast Media; Female; Fluorocarbons; Humans; Image Interpretation, Computer-Assisted; Indoles; Kidney Neoplasms; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Sunitinib; Ultrasonography | 2014 |
1 other study(ies) available for pyrroles and perflutren
| Article | Year |
|---|---|
Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Area Under Curve; Carcinoma, Renal Cell; Contrast Media; Evidence-Based Medicine; Female; Fluorocarbons; Humans; Indoles; Kidney Neoplasms; Male; Microbubbles; Middle Aged; Neoplasm Metastasis; Pyrroles; Reproducibility of Results; Statistics, Nonparametric; Sunitinib; Survival Analysis; Tomography, X-Ray Computed; Ultrasonography | 2011 |